Successful topical treatment of cutaneous sarcoidosis with tacrolimus ointment;Erfolgreiche lokaltherapie einer kutanen sarkoidose mit tacrolimus

Hautarzt

Volumn 54, Issue 12, 2003, Pages 1193-1195

  Gutzmer, R ^a   Volker B ^a   Kapp, A ^a   Werfel, T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cutaneous sarcoidosis; Tacrolimus ointment

Indexed keywords

CORTICOSTEROID; DOXYCYCLINE; FUMARIC ACID; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; ARTICLE; BIOPSY; CASE REPORT; COMPARATIVE STUDY; CUTANEOUS SARCOIDOSIS; FACE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; OINTMENT; PATHOLOGY; PHOTODYNAMIC THERAPY; SARCOIDOSIS; SKIN; SKIN DISEASE; TIME; TREATMENT OUTCOME;

BIOPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; OINTMENTS; SARCOIDOSIS; SKIN; SKIN DISEASES; TACROLIMUS; TIME FACTORS;

EID: 0348077517     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-003-0626-y     Document Type: Article

References (29)

1. Agostini C, Semenzato G (1998) Cytokines in sarcoidosis. Semin Respir Infect 13:184-196
2. Alaiti S, Kang S, Fiedler VC et al. (1998) Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children. J Am Acad Dermatol 38:69-76
3. Bachelez H, Senet P, Cadranel J et al. (2001) The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 137:69-73
4. Brechtel B, Haas N, Henz BM, Kolde G (1996) Allopurinol: a therapeutic alternative for disseminated cutaneous sarcoidosis. Br J Dermatol 135:307-309
5. English JC III, Patel PJ, Greer KE (2001) Sarcoidosis. J Am Acad Dermatol 44:725-743
6. Frizzell B, Stith M, Jenrette J (2002) Management of treatment-resistant cutaneous sarcoidosis with radiation. Am J Clin Oncol 25:573-575
7. Graefe T, Konrad H, Barta U et al. (2001) Successful ultraviolet A1 treatment of cutaneous sarcoidosis. Br J Dermatol 145:354-355
8. Hoch O, Muller S, Buttner G, Mensing H (2001) Thalidomide in the treatment of cutaneous and systemic sarcoidosis. Hautarzt 52:962-965
9. Homey B, Assmann T, Vohr HW et al. (1998) Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses. J Immunol 160:5331-5340
10. Jones E, Callen JP (1990) Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. J Am Acad Dermatol 23:487-489
11. Karrer S, Abels C, Wimmershoff MB et al. (2002) Successful treatment of cutaneous sarcoidosis using topical photodynamic therapy. Arch Dermatol 138:581-584
12. Katoh N, Mihara H, Yasuno H (2002) Cutaneous sarcoidosis successfully treated with topical tacrolimus. Br J Dermatol 147:154-156
13. Liedtka JE (1996) Intralesional chloroquine for the treatment of cutaneous sarcoidosis. Int J Dermatol 35:682-683
14. Mahnke N, Medve-Koenigs K, Megahed M, Neumann NJ (2003) Medium-dose-UV-A1-Phototherapie. Erfolgreiche Behandlung einer kutanen Sarkoidose. Hautarzt 54:364-366
15. Mallbris L, Ljungberg A, Hedblad MA et al. (2003) Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy. J Am Acad Dermatol 48:290-293
16. Nowack U, Gambichler T, Hanefeld C et al. (2002) Successful treatment of recalcitrant cutaneous sarcoidosis with fumaric acid esters. BMC Dermatol 2:15
17. Panhans-Gross A, Novak N, Kraft S, Bieber T (2001) Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506). J Allergy Clin Immunol 107:345-352
18. Pfau A, Stolz W, Karrer S et al. (1998) Allopurinol in treatment of cutaneous sarcoidosis. Hautarzt 49:216-218
19. Rousseau L, Beylot-Barry M, Doutre MS, Beylot C (1998) Cutaneous sarcoidosis successfully treated with low doses of thalidomide. Arch Dermatol 134:1045-1046
20. Ruzicka T, Bieber T, Schopf E et al. (1997) A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 337:816-821
21. Sawada S, Suzuki G, Kawase Y, Takaku F (1987) Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J Immunol 139:1797-1803
22. Schmidt RJ, Bender FH, Chang WW, Teba L (1999) Sarcoidosis after renal transplantation. Transplantation 68:1420-1423
23. Siltzbach LE, Teirstein AS (1964) Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis. Acta Med Scand Suppl 425:302-308
24. Spiteri MA, Taylor SJ (1985) Retinoids in the treatment of cutaneous sarcoidosis. Arch Dermatol 121:1486
25. Veien NK, Brodthagen H (1977) Cutaneous sarcoidosis treated with methotrexate. Br J Dermatol 97:213-216
26. Waldinger TP, Ellis CN, Quint K, Voorhees JJ (1983) Treatment of cutaneous sarcoidosis with isotretinoin. Arch Dermatol 119:1003-1005
27. Webster GF, Razsi LK, Sanchez M, Shupack JL (1991) Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol 24:451-454
28. Wollenberg A, Sharma S, von Bubnoff D et al. (2001) Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol 107:519-525
29. Zic JA, Horowitz DH, Arzubiaga C, King LE Jr (1991) Treatment of cutaneous sarcoidosis with chloroquine. Review of the literature. Arch Dermatol 127:1034-1040